Cargando…

Quality of Life in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy—The Randomized NORDIC9-Study

SIMPLE SUMMARY: Bowel cancer is one of the leading cancer-types in both sexes worldwide. Despite that most new cases and deaths occur in people aged 70 years or older, few clinical trials have investigated the best way to administer chemotherapy in older or frail patients. The NORDIC9-study establis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liposits, Gabor, Eshøj, Henrik Rode, Möller, Sören, Winther, Stine Brændegaard, Skuladottir, Halla, Ryg, Jesper, Hofsli, Eva, Shah, Carl-Henrik, Poulsen, Laurids Østergaard, Berglund, Åke, Qvortrup, Camilla, Österlund, Pia, Glimelius, Bengt, Sorbye, Halfdan, Pfeiffer, Per
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198682/ https://www.ncbi.nlm.nih.gov/pubmed/34073363 http://dx.doi.org/10.3390/cancers13112604

Ejemplares similares

The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy—The Randomized NORDIC9-Study
por: Liposits, Gabor, et al.
Publicado: (2022)

Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients with metastatic colorectal cancer: NORDIC 9
por: Winther, Stine Braendegaard, et al.
Publicado: (2017)

Can we predict toxicity and efficacy in older patients with cancer? Older patients with colorectal cancer as an example
por: Winther, Stine Braendegaard, et al.
Publicado: (2016)

Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study
por: Guren, Tormod Kyrre, et al.
Publicado: (2017)

High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer
por: Siesing, Christina, et al.
Publicado: (2017)

KRAS-G12C Mutation in One Real-Life and Three Population-Based Nordic Cohorts of Metastatic Colorectal Cancer
por: Osterlund, Emerik, et al.
Publicado: (2022)

Plasma YKL-40 in Patients with Metastatic Colorectal Cancer Treated with First Line Oxaliplatin-Based Regimen with or without Cetuximab: RESULTS from the NORDIC VII Study
por: Tarpgaard, Line S., et al.
Publicado: (2014)

High BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumor Tissue Availability in a Prospective Population-Based Metastatic Colorectal Cancer Cohort
por: Sorbye, Halfdan, et al.
Publicado: (2015)

CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup
por: Aasebø, Kristine, et al.
Publicado: (2020)

Consequences of a high incidence of microsatellite instability and BRAF‐mutated tumors: A population‐based cohort of metastatic colorectal cancer patients
por: Aasebø, Kristine Ø., et al.
Publicado: (2019)

A phase II study of daily encorafenib in combination with biweekly cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: the NEW BEACON study
por: Eriksen, Martina, et al.
Publicado: (2022)

Lower treatment intensity and poorer survival in metastatic colorectal cancer patients who live alone
por: Cavalli-Björkman, N, et al.
Publicado: (2012)

Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group
por: Gregersen, Henrik, et al.
Publicado: (2021)

Electronic symptom monitoring in patients with metastatic lung cancer: a feasibility study
por: Friis, Rasmus Blechingberg, et al.
Publicado: (2020)

Overview of the practices of on-farm emergency slaughter of cattle in the Nordic countries
por: Skúladóttir, Gíslína, et al.
Publicado: (2022)

Early radiologic signal of responsiveness to immune checkpoint blockade in microsatellite-stable/mismatch repair-proficient metastatic colorectal cancer
por: Meltzer, Sebastian, et al.
Publicado: (2022)

Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer
por: Mezheyeuski, Artur, et al.
Publicado: (2016)

Clinical characteristics and outcomes among 2347 patients aged ≥85 years with major lymphoma subtypes: a Nordic Lymphoma Group study
por: Wästerlid, Tove, et al.
Publicado: (2020)

Let-7 miRNA-binding site polymorphism in the KRAS 3(′)UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/− cetuximab
por: Kjersem, Janne B, et al.
Publicado: (2012)

Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer
por: Thomsen, Maria, et al.
Publicado: (2016)

Current clinical practice in corneal crosslinking for treatment of progressive keratoconus in four Nordic countries
por: Gustafsson, Ingemar, et al.
Publicado: (2022)

16th Nordic-Baltic Conference on Biomedical Engineering
por: Mindedal, Henrik, et al.
Publicado: (2015)

Reproductive history and risk of colorectal adenocarcinoma in parous women: a Nordic population-based case–control study
por: Bjørge, Tone, et al.
Publicado: (2016)

Outcomes of emergency surgical interventions in right-sided colonic cancer: nationwide population-based study based on Danish Colorectal Cancer Group register
por: El-Hussuna, Alaa, et al.
Publicado: (2023)

Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome
por: Thomsen, Maria, et al.
Publicado: (2018)

Management of patients with Arrhythmogenic Right Ventricular Cardiomyopathy in the Nordic countries
por: Haugaa, Kristina H., et al.
Publicado: (2015)

Neuromuscular Exercises Improve Shoulder Function More Than Standard Care Exercises in Patients With a Traumatic Anterior Shoulder Dislocation: A Randomized Controlled Trial
por: Eshoj, Henrik Rode, et al.
Publicado: (2020)

Monitoring disulfide bond formation in the eukaryotic cytosol
por: Østergaard, Henrik, et al.
Publicado: (2004)

Recurrence Risk after Radical Colorectal Cancer Surgery—Less Than before, But How High Is It?
por: Osterman, Erik, et al.
Publicado: (2020)

Somatic Disease in Survivors of Childhood Malignant Bone Tumors in the Nordic Countries
por: Pedersen, Camilla, et al.
Publicado: (2021)

Translation, adaptation and measurement properties of an electronic version of the Danish Western Ontario Shoulder Instability Index (WOSI)
por: Eshoj, Henrik, et al.
Publicado: (2017)

Feasibility of the SINEX program for patients with traumatic anterior shoulder instability
por: Hagesæter, Amalie Nilssen, et al.
Publicado: (2020)

Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer
por: Glimelius, B, et al.
Publicado: (2011)

Associations between Response to Commonly Used Neo-Adjuvant Schedules in Rectal Cancer and Routinely Collected Clinical and Imaging Parameters
por: Karimi, Masoud, et al.
Publicado: (2022)

Home care patients in four Nordic capitals – predictors of nursing home admission during one-year followup
por: Sørbye, Liv W, et al.
Publicado: (2010)

What Matters at the End of Life: A Qualitative Study of Older Peoples Perspectives in Southern Denmark
por: Hanson, Stine, et al.
Publicado: (2019)

Sex differences in childhood cancer risk among children with major birth defects: a Nordic population-based nested case-control study
por: Daltveit, Dagrun Slettebø, et al.
Publicado: (2022)

Patients with non-operated traumatic primary or recurrent anterior shoulder dislocation have equally poor self-reported and measured shoulder function: a cross-sectional study
por: Eshoj, Henrik, et al.
Publicado: (2019)

Cost-Effectiveness of a New Nordic Diet as a Strategy for Health Promotion
por: Jensen, Jørgen Dejgård, et al.
Publicado: (2015)

Mutation Spectrum in Liquid Versus Solid Biopsies From Patients With Advanced Gastroenteropancreatic Neuroendocrine Carcinoma
por: Knappskog, Stian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_du3lo70qfd73e386o2cmqecbdg